News

Singapore to offer mpox vaccines to at-risk healthcare workers and close contacts, utilizing existing smallpox stock. Health Minister Ong Ye Kung emphasizes the country's ability to manage the virus, drawing on COVID-19 experiences. Insights from Professor Dale Fisher on Singapore's public health response plans.

Countries in Asia are closely watching the Mpox outbreak, with Thailand reporting a suspected case of a more dangerous strain. On "Asia First," Hairianto Diman discusses the potential impact on Singapore with Prof. Dale Fisher from NUS.

Japan is currently facing an unprecedented surge in Streptococcal Toxic Shock Syndrome (STSS), a severe bacterial infection that can be fatal within 48 hours. On MONEY FM 89.3’s “What’s Trending”, Hongbin Jeong and Roshan Gidwani speaks to Prof. Dale Fisher to find out more.

In March 2024, the World Bank enlisted CIDER to provide technical assistance and hands-on proposal writing support to the governments of Papua New Guinea and Solomon Islands for the Pandemic Fund’s second call for proposals, aimed at strengthening pandemic readiness in low- and middle-income countries.

Channel NewsAsia's Glenda Chong speaks to Dr Louisa Sun, Deputy Director of the NUS Centre for Infectious Disease Emergency Response, on the current COVID-19 wave and the outlook as the FLiRT variant spreads around the world.

In February 2024, Dr. Roger Glass, President of the China Medical Board Foundation, invited Prof. Dale Fisher, Director of CIDER, to Cambodia to bolster national laboratory systems through strategic collaboration and networking efforts.

What exactly is Disease X? And how can we prepare for its potential outbreak? On MONEY FM 89.3’s “What’s Trending”, Hongbin Jeong speaks to Professor Dale Fisher, NUS Yong Loo Lin School of Medicine, Senior Consultant, National University Hospital, about this looming disease.

At the 1st APIC-ADVA Asia Pacific Summit on Infectious Diseases and Immunization, Professor Dale Fisher gave an address within Moderna's symposium on the future of mRNA technology in tackling infectious diseases and preparing for the next pandemic.